Holen Sie sich die Stockscreener-App
3.37
1.46%
-0.05
Handel nachbörslich:
3.42
0.05
+1.48%
Finanzdaten der Upstream Bio Inc-Aktie (UPB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
25.24%
0.773
|
1.034 | 0.668 | 0.683 | 0.937 |
| Operating Expenses |
3.38%
43.14
|
44.65 | 46.84 | 38.52 | 45.28 |
| Operating Income/Loss |
2.86%
-42.37
|
-43.62 | -46.17 | -37.83 | -44.35 |
| Nonoperating Income/Loss |
11.84%
2.666
|
3.024 | 3.708 | 4.086 | 4.381 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
2.19%
-39.70
|
-40.59 | -42.46 | -33.75 | -39.97 |
| Basic Average Shares |
0.43%
54.57
|
54.33 | - | 53.93 | 53.77 |
| Diluted Average Shares |
0.43%
54.57
|
54.33 | - | 53.93 | 53.77 |
| Basic Earnings Per Share |
2.67%
-0.73
|
-0.75 | - | -0.63 | -0.74 |
| Diluted Earnings Per Share |
2.67%
-0.73
|
-0.75 | - | -0.63 | -0.74 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):